国药一致：2025年前三季度归属于上市公司股东的净利润95711.85万元

Core Insights - The company reported a total operating revenue of 55,124.49 million yuan for the first three quarters of 2025, representing a year-on-year decline of 2.38% [2] - The net profit attributable to shareholders of the listed company was 957.12 million yuan, showing a year-on-year decrease of 10.18% [2] Financial Performance - Total operating revenue for the first three quarters: 55,124.49 million yuan [2] - Year-on-year change in operating revenue: -2.38% [2] - Net profit attributable to shareholders: 957.12 million yuan [2] - Year-on-year change in net profit: -10.18% [2]